Fernández O - Search Results

1

Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (the Novo Study).

Fernández O, Fernández V, Arbizu T, Izquierdo G, Bosca I, Arroyo R, García Merino JA, de Ramón E; Novo Group. Fernández O, et al. Among authors: fernandez v. J Neurol. 2010 Sep;257(9):1500-7. doi: 10.1007/s00415-010-5560-1. Epub 2010 Apr 10. J Neurol. 2010. PMID: 20383518

2

Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.

Fernández O. Fernández O. J Neurol. 2002 Jan;249(1):1-8. doi: 10.1007/pl00007835. J Neurol. 2002. PMID: 11954855 Review.

3

Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.

Fernández O, Guerrero M, Mayorga C, Muñoz L, Leán A, Luque G, Hervás M, Fernández V, Capdevila A, de Ramón E. Fernández O, et al. Among authors: fernandez v. J Neurol. 2002 Aug;249(8):1058-62. doi: 10.1007/s00415-002-0787-0. J Neurol. 2002. PMID: 12195454

4

Interferon receptor expression in multiple sclerosis patients.

Oliver B, Mayorga C, Fernández V, Leyva L, León A, Luque G, López JC, Tamayo JA, Pinto-Medel MJ, de Ramon E, Blanco E, Alonso A, Fernández O. Oliver B, et al. Among authors: fernandez v, fernandez o. J Neuroimmunol. 2007 Feb;183(1-2):225-31. doi: 10.1016/j.jneuroim.2006.11.010. Epub 2006 Dec 26. J Neuroimmunol. 2007. PMID: 17188754

5

Combination therapy in multiple sclerosis.

Fernández O. Fernández O. J Neurol Sci. 2007 Aug 15;259(1-2):95-103. doi: 10.1016/j.jns.2006.08.019. Epub 2007 May 15. J Neurol Sci. 2007. PMID: 17507031 Review.

6

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

Byun E, Caillier SJ, Montalban X, Villoslada P, Fernández O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR. Byun E, et al. Among authors: fernandez o. Arch Neurol. 2008 Mar;65(3):337-44. doi: 10.1001/archneurol.2008.47. Epub 2008 Jan 14. Arch Neurol. 2008. PMID: 18195134 Clinical Trial.

7

Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study.

O'Connor P, Comi G, Montalban X, Antel J, Radue EW, de Vera A, Pohlmann H, Kappos L; FTY720 D2201 Study Group. O'Connor P, et al. Neurology. 2009 Jan 6;72(1):73-9. doi: 10.1212/01.wnl.0000338569.32367.3d. Neurology. 2009. PMID: 19122034 Clinical Trial.

8

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Fernández O, R-Antigüedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernández-Sánchez V, Leyva L. Fernández O, et al. Among authors: fernandez sanchez v. J Neurol. 2009 Dec;256(12):1977-88. doi: 10.1007/s00415-009-5223-2. J Neurol. 2009. PMID: 19585166

9

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.

Comi G, O'Connor P, Montalban X, Antel J, Radue EW, Karlsson G, Pohlmann H, Aradhye S, Kappos L; FTY720D2201 Study Group. Comi G, et al. Mult Scler. 2010 Feb;16(2):197-207. doi: 10.1177/1352458509357065. Epub 2009 Dec 22. Mult Scler. 2010. PMID: 20028707 Clinical Trial.

10

Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.

Cavanillas ML, Alcina A, Núñez C, de las Heras V, Fernández-Arquero M, Bartolomé M, de la Concha EG, Fernández O, Arroyo R, Matesanz F, Urcelay E. Cavanillas ML, et al. Among authors: fernandez o, fernandez arquero m. Eur J Hum Genet. 2010 Jul;18(7):794-9. doi: 10.1038/ejhg.2010.15. Epub 2010 Feb 24. Eur J Hum Genet. 2010. PMID: 20179739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters